NTHI NASDAQ
Neonc Technologies Holdings, Inc.
1W: -23.2%
1M: +6.4%
3M: -18.2%
YTD: -58.6%
1Y: -62.9%
$3.68
+0.02 (+0.55%)
Weekly Expected Move ±24.4%
$2
$3
$4
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$95.4M
52W Range3.005-12.99
Volume188,306
Avg Volume143,886
Beta0.50
Dividend—
Analyst Ratings
Company Info
CEOAmir Farrokh Heshmatpour
Employees5
SectorHealthcare
IndustryBiotechnology
IPO Date2025-03-26
Websiteneonctech.com
23975 Park Sorrento
Calabasas, CA 91302
US
Calabasas, CA 91302
US
310-663-7831
About Neonc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Latest News
Big Pharma Setbacks Create a New Wave of Rebound Plays
Four Biotech Stories Heating Up Right Now
Quant Check: Top- and bottom-rated small-cap healthcare stocks post-earnings
These Biotech Breakouts and Squeeze Setups Could Be Just Getting Started
The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Heshmatpour Amir F | P-Purchase | 6,000 | $6.51 | 2025-11-24 |
| Heshmatpour Amir F | P-Purchase | 4,000 | $6.50 | 2025-11-21 |
| Heshmatpour Amir F | P-Purchase | 20,000 | $5.98 | 2025-11-21 |
| Neman-Ebrahim Yousha | P-Purchase | 1,100 | $6.69 | 2025-11-20 |
| CHIANG MING-FU (ALAN | 0 | — | 2025-11-12 |